Industry / United States

GE Announces Plans To Buy Vital Signs

July 2008 | Company News Alert

Printable version
Bookmark

Reuters has reported that General Electric (GE) will acquire medical device maker Vital Signs for US$860mn.

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Industry / United States BMI View: The share price of Merck & Co will continue trading sideways until a positive catalyst is introduced. This stimulus is likely to be an enhanced strategy for the high-growth emerging markets...

December 2010

Potential Replacements For Warfarin

Industry / United States BMI View: Stroke prevention is a major therapeutic area in which drugmakers are looking to launch the next blockbuster. The size of the market and the risks associated with the standard warfarin therapy...

December 2010

Telemedicine Demand Exists, But Does It Work?

Industry / United States BMI Core View: Demand for products to aid non-institutional chronic disease management and improve independence among elderly patients will increase. The expected growth of the world's ageing population...

December 2010

Government Offers Innovation Grants To Expand High-Value Domestic Industries

Industry / United States BMI View: Uruguay's global competitiveness will benefit immensely from the current government's efforts to diversify and promote industrial sectors positioned in the upper part of the added value chain....

November 2010

GSK Divests Its Penicillin Manufacturing Site

Industry / United States BMI Core View: The generic drug industry will stratify into the following sub-sectors: unbranded/commodity generics; branded generics; value-added generics; and hard-to-manufacture generics. Branded generics...

November 2010